Diagnosis and Prevention of Scabies in Low Mobility Patients with Cognitive Impairment

Scabies is an infectious skin disease caused by the human-specific ectoparasite Sarcoptes scabiei var. hominis. Despite the comprehensive study of scabies, the problem of its timely diagnosis in low-mobility patients with neurological and cognitive impairments remains relevant all over the world. Simultaneous administration of a large number of medications to patients with limited mobility may mask the clinical manifestations of scabies and mistakenly attribute itching to manifestations of skin allergic reactions or other dermatoses. The authors observed patient K., who was admitted in FCBRN of FMBA of Russia from 14.11.2022 to 15.11.2022. Clinical diagnosis upon admission: I69.3. The consequences of a stroke. Early recovery period of ischemic stroke in the basin of the left middle cerebral artery from 09.08.2022, atherothrombotic subtype according to TOAST criteria. Right-sided hemiparesis. Gross aphasia. Violation of the pelvic organs function. RMS 5. Comorbid diseases: arterial hypertension, controlled, the risk of CVE 4 (very high). The target blood pressure is less than 135/85 mmHg. Occlusion of the left anterior cerebral artery, middle cerebral artery. Toxic-allergic dermatitis (medicinal) in the acute phase. Based on a set of clinical data and laboratory detection of the pathogen, patient K. was diagnosed with B86 — scabies. Even though the patient was under medical supervision at the ambulatory step, scabies was not diagnosed timely. Late diagnosis of scabies leads to the spread of the disease and an unfavorable epidemiological situation.

1. World Health Organization. Scabies. Fact sheets. [Electronic resource]. URL: https://www.who.int/ru/news-room/fact-sheets/detail/scabies (date of the application: 02.12.2022) [In Russian].

2. Sokolova T.V., Gladko V.V., Malyarchuk A.P., et al. Scabies: the seamy side of official statistics. Meditsinskiy vestnik MVD. 2020; 4(107): 68-76 [In Russian].

3. Tlish M.M., Kuznetsova T.G., Naatyzh Zh.Yu., et al. Social epidemiological pattern of scabies in gerontological patients. Russian Medical Journal. 2022; 3: 55–58 [In Russian].

4. Clinical recommendations. Scabies. 2016; 23 р. [Electronic resource]. URL: https://cr.minzdrav.gov.ru/recomend/245_1. (Date of the application: 02.12.2022) [In Russian].

5. Resources and activities of medical organizations of dermatovenerological profile. The incidence of sexually transmitted infections, infectious skin diseases and skin diseases for 2017-2018 (statistical materials). M. 2019; 208 p. [In Russian].

6. Ivanova M.A. The incidence of scabies in various age groups of the population of the Russian Federation in 2010—2014. Klinicheskaya Dermatologiya i Venerologiya. 2016; 15(4): 4-8. DOI: 10.17116/klinderma20161544-8 [In Russian].

7. Shchava S.N., Rusinov V.I., Meshcheryakova K.E., et al. Modern features of the course of scabies in elderly people. Lechebnoe delo. 2021; (1): 117-120. DOI: 10.24412/2071-5315-2021-12297 [In Russian].

8. Thomas C., Coates S.J., Engelman D., et al. Ectoparasites: Scabies. J Am Acad Dermatol. 2020; 82(3): 533-548. DOI: 10.1016/j. jaad.2019.05.109.

9. Arora P., Rudnicka L., Sar-Pomian M., et al. Scabies: A comprehensive review and current perspectives. Dermatol Ther. 2020; 33(4): e13746. doi: 10.1111/dth.13746.

10. Ataeva N.B., Belostotsky A.V., Grishina N.K., et al. The organization of home-nursing medical care of patients with limited mobility. Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2020; 28(2): 306-309. DOI:10.32687/0869-866X-2020-28-2-306-309 [In Russian].

11. Vyortkin A.L., Shevtsova V.A., Sokol A.A., et al. Patients with reduced mobility: critical analysis of situation. Kardiologiya i angiologiya. 2014; 1(8): 10-15 [In Russian].

12. Cassell J.A., Middleton J., Nalabanda A., et al. Scabies outbreaks in ten care homes for elderly people: a prospective study of clinical features, epidemiology, and treatment outcomes. Lancet Infect Dis. 2018; 18(8): 894-902. DOI: 10.1016/S1473-3099(18)30347-5.

13. Engelman D., Yoshizumi J., Hay R.J., et al. The 2020 International Alliance for the Control of Scabies Consensus Criteria for the Diagnosis of Scabies. Br J Dermatol. 2020; 183: 808-820. DOI: 10.1111/bjd.18943.

14. Rosumeck S., Nast A., Dressler C. Ivermectin and permethrin for treating scabies. Cochrane Database Syst Rev. 2018; 4(4): CD012994. DOI: 10.1002/14651858.CD012994.

15. Engelman D., Steer A.C. Control Strategies for Scabies. Trop Med Infect Dis. 2018; 3(3): 98. DOI:10.3390/tropicalmed3030098.

16. Lake S.J., Kaldor J.M., Hardy M., et al. Mass Drug Administration for the Control of Scabies: A Systematic Review and Meta-analysis. Clin Infect Dis. 2022; 75(6): 959-967. DOI:10.1093/cid/ciac042.

17. El-Moamly A.A. Scabies as a part of the World Health Organization roadmap for neglected tropical diseases 2021-2030: what we know and what we need to do for global control. Trop Med Health. 2021; 49(1): 64. DOI:10.1186/s41182-021-00348-6.